Campbell Alliance – Company Fact Sheet
About Campbell Alliance
Founded in 1997, Campbell Alliance (www.campbellalliance.com) is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. From its locations in Raleigh, N.C., Parsippany, N.J., Woodland Hills, Calif., South San Francisco, Chicago, and New York City, the firm serves clients throughout North America, Europe, and Japan.
Campbell Alliance is organized into practice areas, each specializing in a critical industry function.
Brand Management – helps companies plan for and improve the commercial performance of their brands during all stages of the product life cycle—from pre-launch development through maturity
Business Development – helps companies who need assistance developing business development strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals
Clinical Development – assists companies correct or improve processes that are most likely to cause delays or budget overruns in clinical development
Managed Markets – helps companies stay informed about changing reimbursement conditions such as Medicare reform, government policy changes, increasing payer cost constraints, and new benefit and formulary management models as well as understand their implications and more effectively deal with third-party payers
Sales – helps companies take a “total” approach to sales force optimization—and realize superior sales results including sales strategy, analytics, effectiveness, training, and assessment
John J. Campbell, Chief Executive Officer
Using his extensive experience in the pharmaceutical, contract research, and information technology segments of the healthcare industry, John J. Campbell founded Campbell Alliance in 1997. Today, the company is the premier provider of management consulting services to the pharmaceutical and biotech industry.
Before founding Campbell Alliance, Mr. Campbell was an executive with Lawrence Investing Company, a New York-based investment firm; he co-founded HealthMatics, a medical software company, and he was Director of Business Development for the pharmaceutical giant GlaxoWellcome.